Rachel K. King

2016

In 2016, Rachel K. King earned a total compensation of $1.2M as President and Chief Executive Officer at GlycoMimetics, a 10% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$280,543
Option Awards$461,070
Salary$487,900
Other$3,975
Total$1,233,488

King received $487.9K in salary, accounting for 40% of the total pay in 2016.

King also received $280.5K in non-equity incentive plan, $461.1K in option awards and $4K in other compensation.

Rankings

In 2016, Rachel K. King's compensation ranked 7,247th out of 14,075 executives tracked by ExecPay. In other words, King earned more than 48.5% of executives.

ClassificationRankingPercentile
All
7,247
out of 14,075
49th
Division
Manufacturing
2,729
out of 5,489
50th
Major group
Chemicals And Allied Products
895
out of 1,895
53rd
Industry group
Drugs
695
out of 1,538
55th
Industry
Pharmaceutical Preparations
553
out of 1,176
53rd
Source: SEC filing on April 20, 2017.

King's colleagues

We found three more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2016.

2016

Helen Thackray

GlycoMimetics

Chief Medical Officer

2016

John Magnani

GlycoMimetics

Chief Scientific Officer

2016

Brian Hahn

GlycoMimetics

Chief Financial Officer

News

You may also like